NCT01866254View on ClinicalTrials.gov

Use of Intrathecal Hydromorphone in Elective Cesarean Deliveries

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 4, 2017

Study Completion Date

October 22, 2018

Conditions
Pain
Interventions
DRUG

Hydromorphone

Injection of 100 mcg hydromorphone into the intrathecal space

DRUG

Morphine

Injection of 200 mcg of intrathecal morphine

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

Sponsors

Collaborators (1)

Masimo Corporation
All Listed Sponsors
collaborator

Masimo Corporation

INDUSTRY

lead

Grace Shih, MD

OTHER